title: Mitral valve prolapse.
abstract: Mitral Valve Prolapse (MVP) is a common cardiac disorder in our community. It is estimated that 4% to 15% of the general population have the anatomical defect of prolapsed mitral valve leaflets during ventricular systole. Patients with MVP that suffer from chest pain, dyspnea, fatigue, dizziness, syncope, palpitations, cardiac arrhythmias, anxiety, and panic attacks are diagnosed as having Mitral Valve Prolapse Syndrome. There is much controversy in the medical literature as to the causes of MVPS symptomatology. Some scientists believe that autonomic dysfunction, adrenergic, and vagal responsiveness are factors which appropriately explain the symptoms of MVPS. Pharmacological therapy, depending on the severity of the symptoms, is one option for treatment. Education on the etiology of their symptoms, instruction on lifestyle modifications, and reassurance from their physician are appropriate methods for the management of MVPS patients.
authors.affiliation: Baton Rouge General Medical Center, LA 70806.
authors.forename: C C
authors.initials: CC
authors.lastname: Barrett
authors.forename: M
authors.initials: M
authors.lastname: Kirtley
authors.forename: R
authors.initials: R
authors.lastname: Mangham
mesh_terms: D001341:Autonomic Nervous System / Q000503:physiopathology; D002637:Chest Pain / Q000209:etiology; D004562:Electrocardiography; D005260:Female; D006801:Humans; D008019:Life Style; D008945:Mitral Valve Prolapse / Q000175:diagnosis* / Q000628:therapy